Year |
Citation |
Score |
2019 |
Papp N, Koncz S, Kostyalik D, Kitka T, Petschner P, Vas S, Bagdy G. Acute 5-HT Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram. Frontiers in Pharmacology. 10: 1636. PMID 32063851 DOI: 10.3389/Fphar.2019.01636 |
0.604 |
|
2014 |
Kostyalik D, Vas S, Kátai Z, Kitka T, Gyertyán I, Bagdy G, Tóthfalusi L. Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains. Bmc Neuroscience. 15: 120. PMID 25406958 DOI: 10.1186/S12868-014-0120-8 |
0.717 |
|
2013 |
Kátai Z, Adori C, Kitka T, Vas S, Kalmár L, Kostyalik D, Tóthfalusi L, Palkovits M, Bagdy G. Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation. Psychopharmacology. 228: 439-49. PMID 23515582 DOI: 10.1007/S00213-013-3046-4 |
0.715 |
|
2011 |
Kitka T, Adori C, Katai Z, Vas S, Molnar E, Papp RS, Toth ZE, Bagdy G. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation. Neurochemistry International. 59: 686-94. PMID 21740944 DOI: 10.1016/J.Neuint.2011.06.015 |
0.667 |
|
2009 |
Kitka T, Katai Z, Pap D, Molnar E, Adori C, Bagdy G. Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound. Behavioural Brain Research. 205: 482-7. PMID 19665493 DOI: 10.1016/J.Bbr.2009.08.004 |
0.71 |
|
2009 |
Kostyalik D, Vas S, Kitka T, Kátai Z, Bagdy G. Analysis of sleep EEG during rebound sleep after three days REM deprivation Bmc Pharmacology. 9: A45. DOI: 10.1186/1471-2210-9-S2-A45 |
0.704 |
|
2009 |
Kátai Z, Kitka T, Garay T, Molnár E, Bagdy G. P.1.d.010 Peak in the theta power spectrum of EEG shows strong association with voluntary movements in rats European Neuropsychopharmacology. 19: S292-S293. DOI: 10.1016/S0924-977X(09)70432-8 |
0.439 |
|
2008 |
Gyongyosi N, Balogh B, Kirilly E, Kitka T, Kantor S, Bagdy G. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition. Brain Research. 1231: 34-46. PMID 18638459 DOI: 10.1016/J.Brainres.2008.06.099 |
0.648 |
|
Show low-probability matches. |